161 related articles for article (PubMed ID: 31047767)
1. A cell type-specific transcriptomic approach to map B cell and monocyte type I interferon-linked pathogenic signatures in Multiple Sclerosis.
Severa M; Rizzo F; Srinivasan S; Di Dario M; Giacomini E; Buscarinu MC; Cruciani M; Etna MP; Sandini S; Mechelli R; Farina A; Trivedi P; Hertzog PJ; Salvetti M; Farina C; Coccia EM
J Autoimmun; 2019 Jul; 101():1-16. PubMed ID: 31047767
[TBL] [Abstract][Full Text] [Related]
2. Three Copies of Four Interferon Receptor Genes Underlie a Mild Type I Interferonopathy in Down Syndrome.
Kong XF; Worley L; Rinchai D; Bondet V; Jithesh PV; Goulet M; Nonnotte E; Rebillat AS; Conte M; Mircher C; Gürtler N; Liu L; Migaud M; Elanbari M; Habib T; Ma CS; Bustamante J; Abel L; Ravel A; Lyonnet S; Munnich A; Duffy D; Chaussabel D; Casanova JL; Tangye SG; Boisson-Dupuis S; Puel A
J Clin Immunol; 2020 Aug; 40(6):807-819. PubMed ID: 32572726
[TBL] [Abstract][Full Text] [Related]
3. Cell-specific type I IFN signatures in autoimmunity and viral infection: what makes the difference?
Kyogoku C; Smiljanovic B; Grün JR; Biesen R; Schulte-Wrede U; Häupl T; Hiepe F; Alexander T; Radbruch A; Grützkau A
PLoS One; 2013; 8(12):e83776. PubMed ID: 24391825
[TBL] [Abstract][Full Text] [Related]
4. Combining evidence from four immune cell types identifies DNA methylation patterns that implicate functionally distinct pathways during Multiple Sclerosis progression.
Ewing E; Kular L; Fernandes SJ; Karathanasis N; Lagani V; Ruhrmann S; Tsamardinos I; Tegner J; Piehl F; Gomez-Cabrero D; Jagodic M
EBioMedicine; 2019 May; 43():411-423. PubMed ID: 31053557
[TBL] [Abstract][Full Text] [Related]
5. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
Mitsdoerffer M; Schreiner B; Kieseier BC; Neuhaus O; Dichgans J; Hartung HP; Weller M; Wiendl H
J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Monocyte Adhesion and Type I Interferon Signaling by CD52 in Patients With Systemic Sclerosis.
Rudnik M; Rolski F; Jordan S; Mertelj T; Stellato M; Distler O; Blyszczuk P; Kania G
Arthritis Rheumatol; 2021 Sep; 73(9):1720-1730. PubMed ID: 33760395
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte subpopulations, oxidative burst and apoptosis in peripheral blood cells of patients with multiple sclerosis-effect of interferon-beta.
Mix E; Stefan K; Höppner J; Klauer T; Zettl UK; Strauss U; Meyer-Rienecker HJ; Rolfs A
Autoimmunity; 2003 Aug; 36(5):291-305. PubMed ID: 14567559
[TBL] [Abstract][Full Text] [Related]
8. Interferon-β therapy specifically reduces pathogenic memory B cells in multiple sclerosis patients by inducing a FAS-mediated apoptosis.
Rizzo F; Giacomini E; Mechelli R; Buscarinu MC; Salvetti M; Severa M; Coccia EM
Immunol Cell Biol; 2016 Oct; 94(9):886-894. PubMed ID: 27265253
[TBL] [Abstract][Full Text] [Related]
9. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
[TBL] [Abstract][Full Text] [Related]
10. Single Cell Transcriptomics Implicate Novel Monocyte and T Cell Immune Dysregulation in Sarcoidosis.
Garman L; Pelikan RC; Rasmussen A; Lareau CA; Savoy KA; Deshmukh US; Bagavant H; Levin AM; Daouk S; Drake WP; Montgomery CG
Front Immunol; 2020; 11():567342. PubMed ID: 33363531
[TBL] [Abstract][Full Text] [Related]
11. Baseline gene expression signatures in monocytes from multiple sclerosis patients treated with interferon-beta.
Bustamante MF; Nurtdinov RN; Río J; Montalban X; Comabella M
PLoS One; 2013; 8(4):e60994. PubMed ID: 23637780
[TBL] [Abstract][Full Text] [Related]
12. Type I interferon inhibits interleukin-1 production and inflammasome activation.
Guarda G; Braun M; Staehli F; Tardivel A; Mattmann C; Förster I; Farlik M; Decker T; Du Pasquier RA; Romero P; Tschopp J
Immunity; 2011 Feb; 34(2):213-23. PubMed ID: 21349431
[TBL] [Abstract][Full Text] [Related]
13. Interferon (IFN)-beta treatment enhances CD95 and interleukin 10 expression but reduces interferon-gamma producing T cells in MS patients.
Rep MH; Schrijver HM; van Lopik T; Hintzen RQ; Roos MT; Adèr HJ; Polman CH; van Lier RA
J Neuroimmunol; 1999 Apr; 96(1):92-100. PubMed ID: 10227428
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional dysregulation of Interferome in experimental and human Multiple Sclerosis.
Srinivasan S; Severa M; Rizzo F; Menon R; Brini E; Mechelli R; Martinelli V; Hertzog P; Salvetti M; Furlan R; Martino G; Comi G; Coccia EM; Farina C
Sci Rep; 2017 Aug; 7(1):8981. PubMed ID: 28827704
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional profile and Epstein-Barr virus infection status of laser-cut immune infiltrates from the brain of patients with progressive multiple sclerosis.
Veroni C; Serafini B; Rosicarelli B; Fagnani C; Aloisi F
J Neuroinflammation; 2018 Jan; 15(1):18. PubMed ID: 29338732
[TBL] [Abstract][Full Text] [Related]
16. The autoimmune risk gene ZMIZ1 is a vitamin D responsive marker of a molecular phenotype of multiple sclerosis.
Fewings NL; Gatt PN; McKay FC; Parnell GP; Schibeci SD; Edwards J; Basuki MA; Goldinger A; Fabis-Pedrini MJ; Kermode AG; Manrique CP; McCauley JL; Nickles D; Baranzini SE; Burke T; Vucic S; Stewart GJ; Booth DR
J Autoimmun; 2017 Mar; 78():57-69. PubMed ID: 28063629
[TBL] [Abstract][Full Text] [Related]
17. The Long Non-coding RNA NRIR Drives IFN-Response in Monocytes: Implication for Systemic Sclerosis.
Mariotti B; Servaas NH; Rossato M; Tamassia N; Cassatella MA; Cossu M; Beretta L; van der Kroef M; Radstake TRDJ; Bazzoni F
Front Immunol; 2019; 10():100. PubMed ID: 30804934
[TBL] [Abstract][Full Text] [Related]
18. IFN-β therapy modulates B-cell and monocyte crosstalk via TLR7 in multiple sclerosis patients.
Giacomini E; Severa M; Rizzo F; Mechelli R; Annibali V; Ristori G; Riccieri V; Salvetti M; Coccia EM
Eur J Immunol; 2013 Jul; 43(7):1963-72. PubMed ID: 23636665
[TBL] [Abstract][Full Text] [Related]
19. Type I Interferons in the Pathogenesis and Treatment of Autoimmune Diseases.
Jiang J; Zhao M; Chang C; Wu H; Lu Q
Clin Rev Allergy Immunol; 2020 Oct; 59(2):248-272. PubMed ID: 32557263
[TBL] [Abstract][Full Text] [Related]
20. Function of multiple sclerosis-protective HLA class I alleles revealed by genome-wide protein-quantitative trait loci mapping of interferon signalling.
Lundtoft C; Pucholt P; Imgenberg-Kreuz J; Carlsson-Almlöf J; Eloranta ML; Syvänen AC; Nordmark G; Sandling JK; Kockum I; Olsson T; Rönnblom L; Hagberg N
PLoS Genet; 2020 Oct; 16(10):e1009199. PubMed ID: 33104735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
